FerroTrace® Upper GI Clinical Trials
FerroTrace® is currently undergoing clinical trials in upper gastro-intestinal cancer treatment.
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
2024
In Progress
A multi-centre clinical trial in collaboration with Flinders Medical Centre and Royal Adelaide Hospital, South Australia and Austin Health and Peter MacCallum Cancer Centre in Melbourne, Australia.
Magnetic and Indocyanine Green (ICG) Sentinel Lymph Node Mapping in Colorectal Cancer
2024
Completed
Collaboration between Liverpool Hospital, New South Wales, Australia & Colorectal Surgery/Ashford Hospital, South Australia.
Magnetic Sentinel Lymph Node Mapping in Oral Squamous Cell Carcinoma
October 2022
Completed
The Royal Adelaide Hospital, South Australia
FerroTrace® FAPI Research Program
October 2019
In Progress
Collaboration through an NHMRC Grant, between several Australian universities: University of South Australia, University of New South Wales and University of Queensland.
Transforming cancer outcomes through precision surgery, imaging and therapy
Ferronova has developed a surgical oncology tracer system that aims to improve the treatment guidance and staging of complex cancers and help increase survival rates.
Ferronova is backed by
Ferronova
PO Box 554
Prospect East
South Australia 5082
Australia
PO Box 554
Prospect East
South Australia 5082
Australia
Copyright © 2025 | Ferronova, MM3-02, MM Building, UniSA, Mawsons Lakes Blvd, Mawson Lakes SA 5095, Australia. Caution: Ferronova products are undergoing clinical trials and are not approved for commercial use. V4.0.